GB2124901A - Enhancer of anti-tumor effect - Google Patents

Enhancer of anti-tumor effect Download PDF

Info

Publication number
GB2124901A
GB2124901A GB08318159A GB8318159A GB2124901A GB 2124901 A GB2124901 A GB 2124901A GB 08318159 A GB08318159 A GB 08318159A GB 8318159 A GB8318159 A GB 8318159A GB 2124901 A GB2124901 A GB 2124901A
Authority
GB
United Kingdom
Prior art keywords
designates
arabinofuranosyladenine
tumor
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB08318159A
Other languages
English (en)
Other versions
GB8318159D0 (en
Inventor
Shigekazu Nakatsugawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP11949982A external-priority patent/JPS5910518A/ja
Priority claimed from JP11950082A external-priority patent/JPS5910519A/ja
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Publication of GB8318159D0 publication Critical patent/GB8318159D0/en
Publication of GB2124901A publication Critical patent/GB2124901A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08318159A 1982-07-08 1983-07-05 Enhancer of anti-tumor effect Withdrawn GB2124901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11949982A JPS5910518A (ja) 1982-07-08 1982-07-08 抗腫瘍効果増強剤
JP11950082A JPS5910519A (ja) 1982-07-08 1982-07-08 抗腫瘍効果増強剤

Publications (2)

Publication Number Publication Date
GB8318159D0 GB8318159D0 (en) 1983-08-03
GB2124901A true GB2124901A (en) 1984-02-29

Family

ID=26457222

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08318159A Withdrawn GB2124901A (en) 1982-07-08 1983-07-05 Enhancer of anti-tumor effect

Country Status (5)

Country Link
CA (1) CA1214104A (de)
DE (1) DE3323621A1 (de)
FR (1) FR2530142B1 (de)
GB (1) GB2124901A (de)
IT (1) IT1200941B (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053418A1 (de) * 2001-12-20 2003-07-03 Schering Aktiengesellschaft Orale fludara reinst formulierung mit schneller freisetzung des wirkstoffes
US7547776B1 (en) 1997-12-11 2009-06-16 Bayer Schering Pharma Aktiengesellschaft Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1059764A (en) * 1963-03-19 1967-02-22 Tetsu Sato Purine nucleosides and acyl derivatives thereof
GB1381932A (en) * 1971-02-26 1975-01-29 Kyowa Hakko Kogyo Kk Process for producing ribosides of heterocyclic organic bases by fermentation
GB1426469A (en) * 1972-08-10 1976-02-25 Caterpillar Tractor Co Shock-absorbing connections
GB1444412A (en) * 1972-08-04 1976-07-28 Nitto Boseki Co Ltd Process for curing a radiation-curable resin
GB1530912A (en) * 1975-02-13 1978-11-01 Wellcome Found Compositions containing 9-(2-hydroxy-3-alkyl)-adenines
EP0048022A2 (de) * 1980-09-17 1982-03-24 Yamasa Shoyu Kabushiki Kaisha Mittel zum Steigern des Antitumor-Effektes
EP0066915A2 (de) * 1981-05-30 1982-12-15 THE PROCTER & GAMBLE COMPANY Reinigungsmittelzusammensetzung enthaltend einen wirkungsfördernden Zusatz und ein Kopolymer zum Gewährleisten der Verträglichkeit desselben

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS535678B2 (de) * 1973-05-30 1978-03-01
GB1461493A (en) * 1974-03-26 1977-01-13 Icn Pharmaceuticals 9-beta-d-arabinofuranoxyl hypoxanthine nucleotides
CS199093B1 (en) * 1977-10-20 1980-07-31 Antonin Holy Antiviral agent
JPS5735516A (en) * 1980-08-11 1982-02-26 Yamasa Shoyu Co Ltd Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
JPS5883627A (ja) * 1981-11-10 1983-05-19 Yamasa Shoyu Co Ltd 抗腫瘍効果増強剤
JPS58225097A (ja) * 1982-06-23 1983-12-27 Yamasa Shoyu Co Ltd ヌクレオシド５′−アルキルもしくはアルケニルりん酸

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1059764A (en) * 1963-03-19 1967-02-22 Tetsu Sato Purine nucleosides and acyl derivatives thereof
GB1381932A (en) * 1971-02-26 1975-01-29 Kyowa Hakko Kogyo Kk Process for producing ribosides of heterocyclic organic bases by fermentation
GB1444412A (en) * 1972-08-04 1976-07-28 Nitto Boseki Co Ltd Process for curing a radiation-curable resin
GB1426469A (en) * 1972-08-10 1976-02-25 Caterpillar Tractor Co Shock-absorbing connections
GB1530912A (en) * 1975-02-13 1978-11-01 Wellcome Found Compositions containing 9-(2-hydroxy-3-alkyl)-adenines
EP0048022A2 (de) * 1980-09-17 1982-03-24 Yamasa Shoyu Kabushiki Kaisha Mittel zum Steigern des Antitumor-Effektes
EP0066915A2 (de) * 1981-05-30 1982-12-15 THE PROCTER & GAMBLE COMPANY Reinigungsmittelzusammensetzung enthaltend einen wirkungsfördernden Zusatz und ein Kopolymer zum Gewährleisten der Verträglichkeit desselben

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7547776B1 (en) 1997-12-11 2009-06-16 Bayer Schering Pharma Aktiengesellschaft Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%
WO2003053418A1 (de) * 2001-12-20 2003-07-03 Schering Aktiengesellschaft Orale fludara reinst formulierung mit schneller freisetzung des wirkstoffes
US7148207B2 (en) 2001-12-20 2006-12-12 Schering Aktiengesellschaft Oral fludara of high-purity formulation with quick release of active ingredient
CN1306929C (zh) * 2001-12-20 2007-03-28 舍林股份公司 快速释放活性成分的口服氟达拉滨高纯制剂
KR100884685B1 (ko) * 2001-12-20 2009-02-18 바이엘 쉐링 파마 악티엔게젤샤프트 신속 방출 활성 물질을 함유하는 초순도 플루다라 경구제제

Also Published As

Publication number Publication date
IT8348628A0 (it) 1983-07-06
IT1200941B (it) 1989-01-27
FR2530142A1 (fr) 1984-01-20
DE3323621A1 (de) 1984-03-01
CA1214104A (en) 1986-11-18
GB8318159D0 (en) 1983-08-03
FR2530142B1 (fr) 1985-11-22

Similar Documents

Publication Publication Date Title
US4434788A (en) Enhancer of anti-tumor effect
Danneberg et al. Studies on fluorinated pyrimidines: IV. Effects on nucleic acid metabolism in vivo
Prusoff et al. Studies in the mouse of the pharmacology of 5-iododeoxyuridine, an analogue of thymidine
EP0068268B1 (de) Verstärker von Antitumoreffekt
Creasey et al. Biochemical and pharmacological studies with 1-β-d-arabinofuranosylcytosine in man
CA1319931C (en) Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides
US4357324A (en) Prodrug derivatives of 9β-D-arabinofuranosyl-2-fluoroadenine
Barchi Jr et al. Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs
EP0048022B1 (de) Mittel zum Steigern des Antitumor-Effektes
US4880918A (en) Arrest and killing of tumor cells by adenosine 5-diphosphate and adenosine-5-triphosphate
DE19823484A1 (de) 5'-Desoxycytidin-derivate
US4123524A (en) Synthesis of 6-amino-4-methyl-8-(β-D-ribofuranosyl)pyrrolo[4,3,2-de]pyrimido[4,5-C]pyridazine-5'-phosphate as a novel compound and its utility against L-1210 mouse leukemia
SANEYOSHI et al. Synthetic Nucleosides and Nucleotides. XI.: Facile Synthesis and Antitumor Activities of Various 5-Fluoropyrimidine Nucleosides
Lynch et al. Treatment of mouse neoplasms with high doses of tubercidin
GB2124901A (en) Enhancer of anti-tumor effect
DE69533856T2 (de) L-pyranosyl-nukleoside
US10751358B2 (en) Multitargeted nucleoside derivatives
Čihák Transformation of 5-aza-2′-deoxycytidine-3H and its incorporation in different systems of rapidly proliferating cells
Saslaw et al. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice
Tsukamoto et al. Metabolism of Drugs. XXXII. The Metabolic Fate of Secobarbital [5-Allyl-5-(1-methylbutyl) barbituric Acid].
EP0079054A1 (de) Verstärker eines Anti-Tumor-Effektes
Kimball et al. The metabolism of 9-butyl-6-thioguanine in normal and neoplastic tissues
JPS5910519A (ja) 抗腫瘍効果増強剤
DE3007777C2 (de)
JPS5910518A (ja) 抗腫瘍効果増強剤

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)